Wanbury Appoints Pradeep Patni as CEO of India Formulation Business

By siliconindia  |  Wednesday, 21 August 2024, 11:39:05 AM IST

Wanbury Appoints Pradeep Patni as CEO of India Formulation Business
Wanbury Limited has appointed Pradeep Patni as the new Chief Executive Officer (CEO) of its India Formulation Business. Patni, who brings over 25 years of extensive experience in the pharmaceutical sector, previously served as CEO at Akumentis. During his four-year tenure from FY21 to FY24, Patni and his leadership team achieved significant growth, with sales increasing from Rs 233 crore to Rs 398 crore and EBITDA margin improving from 4% to 21%.
Patni holds an MBA from IIM Bangalore and has a robust background in managing business units within major multinational pharmaceutical companies. His expertise covers a broad range of areas including patented and generic molecules, as well as bio-therapeutics. This diverse experience equips him to effectively manage complex market dynamics and drive organizational success.
Patni began his career at Ranbaxy Labs and has since built a distinguished career with notable positions at Janssen, Pfizer Ltd., Abbott Healthcare, and Micro Labs. His appointment at Wanbury reflects the company's commitment to leveraging experienced leadership to drive growth and enhance its formulation business in India.

ON THE DECK

Top Banner

Related Articles